https://data.archives-ouvertes.fr/author/772312

https://data.archives-ouvertes.fr/author/772312

http://xmlns.com/foaf/0.1/topic_interest Checkpoint inhibitors
http://xmlns.com/foaf/0.1/topic_interest Chemotherapy
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/math.math-st
http://xmlns.com/foaf/0.1/topic_interest Gene expression profiling
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest Precision medicine
http://xmlns.com/foaf/0.1/topic_interest Efficacy
http://xmlns.com/foaf/0.1/topic_interest Time Factors
http://xmlns.com/foaf/0.1/topic_interest Allogenic haematopoietic stem cell transplantation
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.mhep.hem
http://xmlns.com/foaf/0.1/topic_interest Ibrutinib
http://xmlns.com/foaf/0.1/topic_interest Adenine
http://xmlns.com/foaf/0.1/topic_interest Idelalisib
http://xmlns.com/foaf/0.1/topic_interest Safety
http://xmlns.com/foaf/0.1/topic_interest Reproducibility of Results
http://xmlns.com/foaf/0.1/topic_interest LC-MS/MS
http://xmlns.com/foaf/0.1/topic_interest Immunotherapy
http://xmlns.com/foaf/0.1/topic_interest Tandem Mass Spectrometry
http://xmlns.com/foaf/0.1/topic_interest Lymphoma
http://xmlns.com/foaf/0.1/topic_interest Male
http://xmlns.com/foaf/0.1/topic_interest Progression
http://xmlns.com/foaf/0.1/topic_interest Anti-PD1
http://xmlns.com/foaf/0.1/topic_interest High Pressure Liquid
http://xmlns.com/foaf/0.1/topic_interest Cerebrospinal fluid
http://xmlns.com/foaf/0.1/topic_interest Risk stratification
http://xmlns.com/foaf/0.1/topic_interest Hodgkin lymphoma
http://xmlns.com/foaf/0.1/topic_interest B-Cell
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bbm.gtp
http://xmlns.com/foaf/0.1/topic_interest Chromatography
http://xmlns.com/foaf/0.1/topic_interest Aspergillosis
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bbm.bc
http://xmlns.com/foaf/0.1/topic_interest Hodgkin''s lymphoma
http://xmlns.com/foaf/0.1/name Charles Herbaux
http://www.w3.org/2002/07/owl#sameAs 0000-0003-4910-476X
http://xmlns.com/foaf/0.1/familyName Herbaux
http://xmlns.com/foaf/0.1/topic_interest Nivolumab
http://xmlns.com/foaf/0.1/topic_interest Polyradiculopathy
http://xmlns.com/foaf/0.1/topic_interest Indolent
http://xmlns.com/foaf/0.1/topic_interest Waldenström macroglobulinemia
http://xmlns.com/foaf/0.1/topic_interest Humans
http://xmlns.com/foaf/0.1/topic_interest Hodgkin's Lymphoma
http://xmlns.com/foaf/0.1/topic_interest Peripheral T cell lymphoma
http://xmlns.com/foaf/0.1/topic_interest B-cell malignancies
http://xmlns.com/foaf/0.1/topic_interest Dihydrodiol-ibrutinib
http://xmlns.com/foaf/0.1/topic_interest BACH2
http://xmlns.com/foaf/0.1/topic_interest Lymphocytic
http://xmlns.com/foaf/0.1/topic_interest Pyrazoles
http://xmlns.com/foaf/0.1/topic_interest Multiple myeloma
http://xmlns.com/foaf/0.1/firstName Charles
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/topic_interest Pyrimidines
http://xmlns.com/foaf/0.1/topic_interest Cell Therapy and Immunotherapy
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.gen
http://xmlns.com/foaf/0.1/topic_interest Re-sensitization
http://xmlns.com/foaf/0.1/topic_interest Chronic
http://xmlns.com/foaf/0.1/topic_interest Limit of Detection
http://xmlns.com/foaf/0.1/topic_interest Physiopathology
http://xmlns.com/foaf/0.1/topic_interest Female
http://xmlns.com/foaf/0.1/topic_interest Anti-PD-1
http://xmlns.com/foaf/0.1/topic_interest Leukemia
http://xmlns.com/foaf/0.1/topic_interest Bendamustine
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.imm.imm

Télécharger au format